95M8R751W8
Ro-18-0647/002
Alli
SMR000466339
BDBM24567
Tetrahydrolipstatin|||Ro 18-0647/002
CS-2165
ZLA0015
GTPL5277
L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
LEU002
N-formyl-L-leucine (1S)-1-{[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl}dodecyl ester
Orlipastat
(-)-tetrahydrolipostatin
Orlistat [USAN:INN]
1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate
R-212
AB00639987_10
Roche brand of orlistat
AN-15658
SR-01000759417-7
CCG-100851
UNII-95M8R751W8
DB01083
[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate
HSDB 7556
MLS000759448
N-formyl-L-leucine-(S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]-dodecyl ester
(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl (2S)-2-formamido-4-methylpentanoate
Orlistat, United States Pharmacopeia (USP) Reference Standard
Ro 18-0647/008
AHLBNYSZXLDEJQ-FWEHEUNISA-N
SC-16265
BCP0726000044
tetrahydrolipastatin
CHEMBL175247
Z2379810072
FT-0601570
KS-1183
MolPort-005-938-035
NCGC00165856-02
Orlistat (USAN/INN)
(S)-((S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) 2-formamido-4-methylpentanoate
PubChem18271
96829-58-2
Ro-180647-002
Alli (TN)
SR-01000759417
BIDD:GT0853
THL
D04028
zlchem 13
HMS2051I08
L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))-
LS-178328
N-formyl-L-leucine (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
Orlipastatum
(-)-Tetrahydrolipstatin
Orlistat, >=98%, solid
111397-16-1
RL06088
AB1009256
s1629
AOB6737
ST24048848
CHEBI:94686
Xenical
DTXSID8023395
HY-B0218
MLS001423955
NC00101
Orlistat (Alli, Xenical)
(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl N-formyl-L-leucinate
Orlistat,Tetrahydolipstat
829O582
Ro-18-0647
AKOS015894875
SCHEMBL16408
BCP9001031
Tetrahydrolipstatin
CPD000466339
ZINC8214635
GlaxoSmithKline brand of orlistat
L-Leucine, N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester
N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
O0381
Orlistat [USAN:INN:BAN]
(S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl formyl-L-leucinate
Q-201519
AB00639987-09
Ro-180647002
Alli, Xenical, Tetrahydrolipstatin, Orlistat
SR-01000759417-5
C29H53NO5
THLP
D0T9TJ
[(1S)-1-[[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate
Hoffmann-La Roche brand of orlistat
L-Leucine,N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester
MFCD05662360
N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone
Orlipastatum [INN-Latin]
(-)-Tetrahydrolipstatin; N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl] dodecyl ester; Ro-18-0647
Orlistat, Pharmaceutical Secondary Standard; Certified Reference Material
2-formamido-3-[(3-hexyl-4-oxo-oxetan-2-yl)methyl]-2-isobutyl-tetradecanoate
Ro 18-0647/002
AC1MHWQP
SAM001246637
BC214880
SW197481-2
Xenical (TN)
FT-0082584
J90006